Projects per year
Personal profile
Education
- 2007 亞利桑那大學藥事經濟博士
- 2003 伊利諾大學芝加哥分校藥學管理碩士
- 1999 臺灣大學藥學系學士
Experience
- 2020- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2020- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2016- Director, Research Center of Pharmacoeconomics, College of Pharmacy, Taipei Medical University
- 2015-2020 Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2015-2020 Associate Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2009-2014 Assistant Professor, University of Singapore
- 2007-2009 Postdoctoral researcher, University of Singapore
Research Interests
- 藥事經濟暨效果研究
- 用藥安全
- 心理計量學
- 健康照護服務研究
Fingerprint
Dive into the research topics where Yu Ko is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
建置常見疾病的本土藥物經濟模型並運用醫療科技評估方法探討健保給付醫療措施之效益
1/23/17 → 12/31/19
Project: A - Government Institution › f - Other (Funded by Government)
-
Outcomes research in gout: economic impact, humanistic burden, and pharmacoeconomic evaluation
1/1/16 → 12/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
-
104年度科學及技術類委託研究計畫「健保已給付新藥副作用之風險評估_以口服抗凝血劑為例」計畫案
Chien, L., Ko, Y., Chien, S. & Chi, N.
12/23/15 → 12/22/16
Project: A - Government Institution › c - Ministry of Health and Welfare
-
Febuxostat 和 Allopurionol 用於慢性腎臟病病人的成本效益分析
5/1/15 → 4/30/17
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk
Huang, W. C., Chen, Y. C., Wu, C. H. & Ko, Y., Dec 2021, In: Scientific Reports. 11, 1, 1430.Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan
Lin, Y. J., Kuo, C. N. & Ko, Y., Jun 2021, In: Breast. 57, p. 18-24 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan
Diaby, V., Alqhtani, H., van Boemmel-Wegmann, S., Wang, C. Y., Ali, A. A., Balkrishnan, R., Ko, Y., Palacio, S. & de Lima Lopes, G., Feb 1 2020, In: Breast. 49, p. 141-148 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
An assessment of the psychometric properties of the Chinese version of the Gout Impact Scale
Pao, C. H. & Ko, Y., Jan 2 2020, In: Current Medical Research and Opinion. 36, 1, p. 17-21 5 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Conceptualization, development and psychometric evaluations of a new medication-related health literacy instrument: The chinese medication literacy measurement
Lin, H. W., Chang, E. H., Ko, Y., Wang, C. Y., Wang, Y. S., Mafruhah, O. R., Wu, S. H., Chen, Y. C. & Huang, Y. M., Oct 1 2020, In: International journal of environmental research and public health. 17, 19, p. 1-17 17 p., 6951.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
Chien, C. (Contributor), Chen, Y. (Contributor), Malone, D. C. (Contributor), Peng, Y. (Contributor) & Ko, Y. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12871744.v1, https://tandf.figshare.com/articles/dataset/Cost-utility_analysis_of_second-line_anti-diabetic_therapy_in_patients_with_type_2_diabetes_mellitus_inadequately_controlled_on_metformin/12871744/1
Dataset
-
Patient preferences for diabetes-related complications in Taiwan
Lin, Y. (Contributor), Wang, C. (Contributor), Cheng, S. (Contributor) & Ko, Y. (Contributor), Unknown Publisher, Jan 2 2019
DOI: 10.6084/m9.figshare.6194663.v1, https://tandf.figshare.com/articles/Patient_preferences_for_diabetes-related_complications_in_Taiwan/6194663/1
Dataset